Biography
Dr. Roll completed both general surgery training and the abdominal organ transplant fellowship at the University of California San Francisco. During his training, Dr. Roll spent 2 years in Dr. Holger Willenbring's laboratory investigating liver cell therapy, as well as normal and pathologic liver regeneration. After fellowship Dr. Roll moved to England to become a Senior International Fellow in Liver Transplant and Multi Organ Procurement at Queen Elizabeth Hospital, Birmingham, one of the busiest liver transplant departments in the United Kingdom. There he gained valuable experience in the blossoming field of DCD liver transplant and normothermic machine liver perfusion prior to returning to UCSF.
Since returning to UCSF in 2015, Dr. Roll has specialized in abdominal organ transplantation for both adults and children, including liver and kidney transplant surgery from living donors, complex hepatobiliary surgery, and kidney autotransplants for intractable ureteral problems. He also performs general surgery in patients with end-stage organ disease and patients taking immunosuppression. His expertise includes using minimally invasive surgical techniques.
Within UCSF, Dr. Roll is an investigator on several clinical trials looking at outcomes for organ transplant recipients and advance organ preservation. He has leadership roles in patient safety and quality improvement at UCSF, in addition to teaching medical students and residents in multiple forums. Outside of UCSF, he serves on the editorial board of multiple peer reviewed journals.
Education
Boston College, BS, Finance, 1995-1999
Brandeis University, Post Baccalaureate, Premedical, 1999-2001
Temple University School of Medicine, MD, 2001-2005
University of California, San Francisco, General Surgery, 2005-2012
Board Certifications
American Board of Surgery, General Surgery
Clinical Expertise
Ascites
Bile Duct Cancer (Cholangiocarcinoma)
Bile Duct Injuries
Bile Duct Strictures
Bridging Therapies to Downstage HCC in Liver Transplant Setting
Choledochal Cysts
Deceased Donor Organ Utilization
Gallbladder Cancer
Kidney Transplantation
Laparoscopic Donor Nephrectomy
Liver Biopsy
Hepatocellular Carcinoma (Primary Liver Cancer)
Liver Cysts
Liver Metastases (Secondary Liver Cancer)
Liver Resection
Liver Transplantation
Living Donor Kidney Transplantation
Living Donor Liver Transplantation
Normothetic Machine Liver Perfusion
Organ Donation of Cardiovascular Death
Pancreas Transplantation
Pediatric Kidney Transplantation
Pediatric Liver Transplantation
Portal Hypertension
Clinical Interests
Transplantation
HBP surgery
Clinical Trials
- US National OCS Liver Perfusion (OLP) Registry (NCT05940857)Related Conditions: Liver Transplant| Start Date: | End Date:
- Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) (NCT06263426)Related Conditions: HIV/AIDS, Kidney Transplant| Start Date: | End Date:
In the News
Research Interests
Cell therapy with hepatocytes and hepatocyte-like cells derived from stem cells.
Role of miRNA in liver regeneration
Normothetic machine liver perfusion
Publications
- Steroid Avoidance After Adult Living Donor Liver Transplant: A Cohort Analysis.| | PubMed
- Advances and innovations in living donor liver transplant techniques, matching and surgical training: Meeting report from the living donor liver transplant consensus conference.| | PubMed
- COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort.| | PubMed
- Number of Local Regional Therapies for Hepatocellular Carcinoma and Peri-Operative Outcomes after Liver Transplantation.| | PubMed
- Simultaneous thoracic and abdominal donation after circulatory death organ recovery: the abdominal surgeon's perspective.| | PubMed
- Comparison of Biliary Complications Rates After Brain Death, Donation After Circulatory Death, and Living-Donor Liver Transplantation: A Single-Center Cohort Study.| | PubMed
- Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study.| | PubMed
- Which recipient pretransplant factors, such as MELD, renal function, sarcopenia, and recent sepsis influence suitability for and outcome after living donor liver transplantation? A systematic review of the literature and expert panel recommendations.| | PubMed
- 214.1: Strategies to Achieve Long-term Insulin Independence Using a Multimodal Approach to Beta-cell Replacement in Patients With Type I Diabetes.| | UCSF Research Profile
- 335.4: Use of Donation After Circulatory Death Donors for High Model for End-Stage Liver Disease Recipients.| | UCSF Research Profile